Patents by Inventor Kevin Whittlesey

Kevin Whittlesey has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • CODON OPTIMIZED GLA GENES AND USES THEREOF
    Publication number: 20240018498
    Abstract: The present disclosure provides codon optimized nucleotide sequences encoding hum n alpha-galactosidase A, vectors, and host cells comprising codon optimized alpha-galactosidase A sequences, and methods of treating disorders such as Fabry disease comprising administering to the subject a codon optimized sequence encoding human alpha-galactosidase A.
    Type: Application
    Filed: September 8, 2023
    Publication date: January 18, 2024
    Applicant: 4D MOLECULAR THERAPEUTICS INC.
    Inventors: David H. KIRN, Melissa KOTTERMAN, Peter FRANCIS, David SCHAFFER, Paul SZYMANSKI, Kevin WHITTLESEY
  • Codon optimized GLA genes and uses thereof
    Patent number: 11802278
    Abstract: The present disclosure provides codon optimized nucleotide sequences encoding human alpha-galactosidase A, vectors, and host cells comprising codon optimized alpha-galactosidase A sequences, and methods of treating disorders such as Fabry disease comprising administering to the subject a codon optimized sequence encoding human alpha-galactosidase A.
    Type: Grant
    Filed: October 11, 2022
    Date of Patent: October 31, 2023
    Inventors: David H. Kirn, Melissa Kotterman, Peter Francis, David Schaffer, Paul Szymanski, Kevin Whittlesey
  • CODON OPTIMIZED GLA GENES AND USES THEREOF
    Publication number: 20230190964
    Abstract: The present disclosure provides codon optimized nucleotide sequences encoding human alpha-galactosidase A, vectors, and host cells comprising codon optimized alpha-galactosidase A sequences, and methods of treating disorders such as Fabry disease comprising administering to the subject a codon optimized sequence encoding human alpha-galactosidase A.
    Type: Application
    Filed: October 11, 2022
    Publication date: June 22, 2023
    Applicant: 4D MOLECULAR THERAPEUTICS INC.
    Inventors: David H. Kirn, Melissa Kotterman, Peter Francis, David Schaffer, Paul Szymanski, Kevin Whittlesey
  • Codon optimized GLA genes and uses thereof
    Patent number: 11198858
    Abstract: The present disclosure provides codon optimized nucleotide sequences encoding human alpha-galactosidase A, vectors, and host cells comprising codon optimized alpha-galactosidase A sequences, and methods of treating disorders such as Fabry disease comprising administering to the subject a codon optimized sequence encoding human alpha-galactosidase A.
    Type: Grant
    Filed: April 26, 2021
    Date of Patent: December 14, 2021
    Assignee: 4D Molecular Therapeutics Inc.
    Inventors: David H. Kirn, Melissa Kotterman, Peter Francis, David Schaffer, Paul Szymanski, Kevin Whittlesey
  • CODON OPTIMIZED GLA GENES AND USES THEREOF
    Publication number: 20210332341
    Abstract: The present disclosure provides codon optimized nucleotide sequences encoding human alpha-galactosidase A, vectors, and host cells comprising codon optimized alpha-galactosidase A sequences, and methods of treating disorders such as Fabry disease comprising administering to the subject a codon optimized sequence encoding human alpha-galactosidase A.
    Type: Application
    Filed: April 26, 2021
    Publication date: October 28, 2021
    Applicant: 4D MOLECULAR THERAPEUTICS INC.
    Inventors: David H. KIRN, Melissa KOTTERMAN, Peter FRANCIS, David SCHAFFER, Paul SZYMANSKI, Kevin WHITTLESEY
  • Biodegradable scaffolds and uses thereof
    Patent number: 7846466
    Abstract: The invention is directed to scaffolds containing porous polymer material prepared by a process of gas foaming/particulate leaching and a wet granulation step prior to gas foaming and particulate leaching, particularly having a characteristic interconnected pore structure, as well as sustained release of protein, DNA or cells, and to methods for using such porous polymer material for preparation of scaffolds, particularly for tissue engineering.
    Type: Grant
    Filed: June 9, 2005
    Date of Patent: December 7, 2010
    Assignee: Northwestern University
    Inventors: Lonnie D. Shea, Lonnie L. Shea, Kevin Whittlesey, Yang Yang, Christopher Rives, Laura De LaPorte, Jae-Hyung Jang
  • Biodegradable scaffolds and uses thereof
    Publication number: 20060002978
    Abstract: The invention is directed to scaffolds containing porous polymer material prepared by a process of gas foaming/particulate leaching and a wet granulation step prior to gas foaming and particulate leaching, particularly having a characteristic interconnected pore structure, as well as sustained release of protein, DNA or cells, and to methods for using such porous polymer material for preparation of scaffolds, particularly for tissue engineering.
    Type: Application
    Filed: June 9, 2005
    Publication date: January 5, 2006
    Inventors: Lonnie Shea, Lonnie Shea, Kevin Whittlesey, Yang Yang, Christopher Rives, Laura De LaPorte, Jae-Hyung Jang